SCHEMBL24469549

SCHEMBL24469549

CC(C)n1c(=O)cc(N[C@@H](C)c2ccc3c(c2)OCC3)[nH]c1=O

nearest known ligand 0.59

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2B6 P20813 1/20 0.59
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ OGA O60502 17/20 0.38
▸ IDH1 O75874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24469573 1.00 CYP3A4 (0.59) CYP3A4CYP2B6HTTSMN1; SMN2OGA
SCHEMBL24469529 0.91 CYP3A4 (0.59) CYP3A4CYP2B6HTTSMN1; SMN2OGA
SCHEMBL24469572 0.84 CYP3A4 (0.67) CYP3A4CYP2B6HTTSMN1; SMN2
SCHEMBL30599769 0.84 CYP3A4 (0.67) CYP3A4CYP2B6HTTSMN1; SMN2
SCHEMBL24469516 0.84 CYP3A4 (0.67) CYP3A4CYP2B6HTTSMN1; SMN2
SCHEMBL16322368 0.83 CYP3A4 (0.62) CYP3A4CYP2B6HTTSMN1; SMN2OGA
SCHEMBL16322370 0.83 CYP3A4 (0.62) CYP3A4CYP2B6HTTSMN1; SMN2OGA
SCHEMBL24469575 0.82 CYP3A4 (0.64) CYP3A4CYP2B6HTTSMN1; SMN2
SCHEMBL24469576 0.82 CYP3A4 (0.64) CYP3A4CYP2B6HTTSMN1; SMN2
SCHEMBL24469574 0.82 CYP3A4 (0.64) CYP3A4CYP2B6HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507621-A Pyrimidine diketone derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-07-28 — — CN disclosed
WO-2022111498-A1 PYRIMIDINEDIONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-06-02 — — WO disclosed
WO-2022111498-A1 PYRIMIDINEDIONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-06-02 — — WO disclosed
Send feedback